Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-20 Sale |
2024-12-26 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $11.49 | $1,149,000 | 12,821,814 (Direct) |
View |
| 2024-12-18 Sale |
2024-12-20 9:00 pm |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $12.05 | $4,971,637 | 34,947,147 (Direct) |
View |
| 2024-11-20 Sale |
2024-11-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $11.32 | $1,132,000 | 12,932,759 (Direct) |
View |
| 2024-10-21 Sale |
2024-10-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $11.65 | $1,165,000 | 13,043,704 (Direct) |
View |
| 2024-09-25 Sale |
2024-09-26 9:22 pm |
Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director |
926,000 | $11.82 | $10,942,820 | 65,793,779 (Indirect) |
View |
| 2024-09-24 Sale |
2024-09-26 8:35 pm |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
503,000 | $11.66 | $5,866,308 | 1,277,178 (Direct) |
View |
| 2024-09-24 Sale |
2024-09-26 8:34 pm |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
4,426,000 | $11.71 | $51,820,727 | 26,911,188 (Indirect Direct) |
View |
| 2024-09-23 Sale |
2024-09-24 9:01 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
1,983,257 | $11.79 | $23,382,600 | 32,843,727 (Direct) |
View |
| 2024-09-23 Sale |
2024-09-24 9:01 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
250,000 | $11.89 | $2,972,500 | 709,322 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-20 Exercise |
2024-12-26 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 12,821,814 (Direct) |
View |
| 2024-12-20 Exercise |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 12,821,814 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $11.57 | 12,821,814 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.57 | 17,339,169 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-20 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $0 | 34,947,147 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-20 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $3.85 | 34,947,147 (Direct) |
View |
| 2024-12-03 Other |
2024-12-05 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
3,651,985 | $12.21 | 22,488,532 (Direct) |
View |
| 2024-11-28 Tax Withholding |
2024-12-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,341 | $12.69 | 276,601 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
958 | $11.49 | 207,408 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-22 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 12,932,759 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 12,932,759 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $11.49 | 12,932,759 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.49 | 17,350,114 (Direct) |
View |
| 2024-10-28 Tax Withholding |
2024-10-30 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,341 | $11.84 | 278,942 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
1,231 | $0 | 93,665 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
1,613 | $0 | 38,037 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
2,303 | $0 | 97,856 (Direct) |
View |
| 2024-10-21 Exercise |
2024-10-22 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 13,043,704 (Direct) |
View |
| 2024-10-21 Exercise |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 13,043,704 (Direct) |
View |
| 2024-10-20 Tax Withholding |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $11.92 | 13,043,704 (Direct) |
View |
| 2024-10-20 Tax Withholding |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
956 | $11.92 | 208,366 (Direct) |
View |
| 2024-10-20 Tax Withholding |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.92 | 17,361,059 (Direct) |
View |
| 2024-09-28 Tax Withholding |
2024-10-01 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,340 | $11.48 | 281,283 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 9:01 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
1,550,000 | $0 | 32,843,727 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
1,550,000 | $3.85 | 32,843,727 (Direct) |
View |
| 2024-09-23 Other |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
498,539 | $11.97 | 32,843,727 (Direct) |
View |
| 2024-09-20 Tax Withholding |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.97 | 32,843,727 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 9:01 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
250,000 | $0 | 709,322 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
250,000 | $3.85 | 709,322 (Direct) |
View |
| 2024-09-20 Tax Withholding |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
3,087 | $11.97 | 709,322 (Direct) |
View |
| 2024-09-20 Tax Withholding |
2024-09-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,129 | $11.97 | 283,623 (Direct) |
View |
| 2024-09-20 Tax Withholding |
2024-09-24 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $11.97 | 628,415 (Direct) |
View |
| 2024-09-12 Other |
2024-09-16 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
3,487 | $12.12 | 99,040 (Direct) |
View |
| 2024-09-12 Other |
2024-09-16 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
3,056 | $12.12 | 95,490 (Direct) |
View |
| 2024-09-12 Other |
2024-09-16 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
4,245 | $12.12 | 40,669 (Direct) |
View |
| 2024-09-12 Other |
2024-09-16 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
2,599 | $12.12 | 9,947,937 (Direct) |
View |
| 2024-09-12 Other |
2024-09-16 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director |
894 | $12.12 | 30,270 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 9:00 pm |
N/A 2034-09-09 |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
44,300 | $0 | 9,975,831 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 9:00 pm |
N/A 2034-09-09 |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
44,300 | $0 | 1,808,072 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 9:00 pm |
N/A 2034-09-09 |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
44,300 | $0 | 68,563 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 9:00 pm |
N/A 2034-09-09 |
Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director |
44,300 | $0 | 58,164 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 9:00 pm |
N/A 2034-09-09 |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
44,300 | $0 | 126,934 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 9:00 pm |
N/A 2034-09-09 |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
44,300 | $0 | 123,384 (Direct) |
View |
| 2024-08-28 Tax Withholding |
2024-08-30 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,341 | $12 | 285,752 (Direct) |
View |
| 2024-08-20 Tax Withholding |
2024-08-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
958 | $11.48 | 212,409 (Direct) |
View |
| 2024-08-20 Tax Withholding |
2024-08-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,947 | $11.48 | 639,360 (Direct) |
View |
| 2024-08-20 Tax Withholding |
2024-08-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,947 | $11.48 | 18,314,745 (Direct) |
View |
| 2024-07-26 Option Award |
2024-07-30 9:04 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
17,204,821 | $0 | 18,325,692 (Direct) |
View |
| 2024-07-26 Option Award |
2024-07-30 9:02 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
18,836,547 | $0 | 24,146,230 (Direct) |
View |